Biochemical basis for the "riboflavin defect" associated with the use of oral contraceptives. A study in female rats.
D000818:Animals; D003276:Contraceptives, Oral / Q000494:pharmacology*; D003277:Contraceptives, Oral, Combined / Q000494:pharmacology*; D003605:D-Amino-Acid Oxidase / Q000378:metabolism; D004032:Diet; D004997:Ethinyl Estradiol / Q000494:pharmacology*; D005040:Ethynodiol Diacetate / Q000494:pharmacology*; D005260:Female; D005182:Flavin-Adenine Dinucleotide / Q000378:metabolism; D005980:Glutathione Reductase / Q000378:metabolism; D008099:Liver / Q000201:enzymology* / Q000378:metabolism; D009247:NADH, NADPH Oxidoreductases / Q000378:metabolism; D011734:Pyridoxaminephosphate Oxidase / Q000378:metabolism; D051381:Rats; D012256:Riboflavin / Q000097:blood / Q000378:metabolism* / Q000652:urine; D014969:Xanthine Oxidase / Q000378:metabolism
D003276:Contraceptives, Oral; D003277:Contraceptives, Oral, Combined; D005182:Flavin-Adenine Dinucleotide; D004997:Ethinyl Estradiol; D005040:Ethynodiol Diacetate; D014969:Xanthine Oxidase; D003605:D-Amino-Acid Oxidase; D011734:Pyridoxaminephosphate Oxidase; D009247:NADH, NADPH Oxidoreductases; D005980:Glutathione Reductase; D012256:Riboflavin